Sensus Healthcare, Inc. (SRTS) Earnings History
Net Loss12 years of earnings data (2014–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Sensus Healthcare, Inc. (SRTS) Earnings Overview
As of June 29, 2026, Sensus Healthcare, Inc. (SRTS) reported trailing twelve-month net income of -$8M, reflecting -214.6% year-over-year growth. The company earned $-0.47 per diluted share over the past four quarters, with a net profit margin of -28.1%.
Looking at the long-term picture, SRTS's historical earnings data spans multiple years. The company achieved its highest annual net income of $24M in fiscal 2022.
Sensus Healthcare, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including XTLB (-$1M net income, -227.7% margin), STXS (-$22M net income, -66.8% margin), ARAY (-$46M net income, -0.3% margin), SRTS has outperformed on profitability metrics. Compare SRTS vs XTLB →
SRTS Earnings vs Peers
Earnings metrics vs comparable public companies
SRTS Historical Earnings Data (2014–2025)
12 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$8M | -216.1% | -$10M | $-0.47 | -28.1% | -37.5% |
| 2024 | $7M | +1270.5% | $8M | $0.41 | 15.9% | 19.4% |
| 2023 | $485,000 | -98.0% | $-382,000 | $0.03 | 2.0% | -1.6% |
| 2022 | $24M | +488.6% | $15M | $1.46 | 54.4% | 33.3% |
| 2021 | $4M | +160.3% | $4M | $0.25 | 15.2% | 15.2% |
| 2020 | -$7M | -302.1% | -$8M | $-0.42 | -71.4% | -86.0% |
| 2019 | -$2M | +16.0% | -$2M | $-0.07 | -6.2% | -7.2% |
| 2018 | -$2M | +45.5% | -$2M | $-0.14 | -7.7% | -7.6% |
| 2017 | -$4M | -971.0% | -$4M | $-0.28 | -18.0% | -18.1% |
| 2016 | $-346,448 | -46.0% | $-363,119 | $-0.03 | -2.3% | -2.5% |
| 2015 | $-237,267 | +93.6% | $-221,257 | $-0.02 | -2.3% | -2.2% |
| 2014 | -$4M | - | -$4M | $-0.37 | -63.7% | -63.3% |
Download Data
Export SRTS earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
12+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
SRTS — Frequently Asked Questions
Quick answers to the most common questions about buying SRTS stock.
What is SRTS earnings per share (EPS)?
SRTS trailing twelve-month (TTM) diluted EPS is $-0.47, reflecting -214.6% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2014 to 2025 is available in the table on this page.
What is Sensus Healthcare, Inc.'s net income?
Sensus Healthcare, Inc. (SRTS) trailing twelve-month net income is $-8M as of 2025. Earnings declined -214.6% year-over-year.
Is SRTS profitable?
SRTS is not currently profitable on a TTM basis, reporting a net loss of $-8M. Net margin is -28.1%. Investors should monitor for a return to profitability.
What is SRTS's earnings growth rate?
SRTS compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2014 to 2025.
What are SRTS's profit margins?
Sensus Healthcare, Inc. net profit margin is -28.1%, operating margin is -37.5%, and gross margin is +43.2%. Below-average margins reflect competitive or cost pressures. Return on Equity is -14.9%.
Is SRTS growing earnings?
SRTS earnings are declining — EPS fell -214.6% year-over-year. TTM net income dropped to $-8M. This contrasts with the 5-year CAGR of N/A.
What was SRTS's best earnings year?
Sensus Healthcare, Inc.'s highest annual net income on record is $24M, achieved in fiscal year 2022. Earnings history on this page spans 2014 to 2025 and includes all annual and quarterly figures.
What were SRTS's earnings last quarter?
SRTS's most recent reported quarter was Q1 2026. Net income was $-3M with diluted EPS of $-0.16. For a full breakdown of all quarters, see the quarterly earnings table on this page.